Ramalin Isolated from Ramalina Terebrata Attenuates Atopic Dermatitis-like Skin Lesions in Balb/c Mice and Cutaneous Immune Responses in Keratinocytes and Mast Cells

Phytotherapy Research

Volumn 30, Issue 12, 2016, Pages 1978-1987

  Park, Hye Jin ^a   Jang, Yeon Jeong ^a   Yim, Joung Han ^b   Lee, Hong Kum ^b   Pyo, Suhkneung ^a  

^a Sungkyunkwan University   (South Korea)

^b Korea Polar Research Institute (KOPRI)   (South Korea)

Author keywords

atopic dermatitis; Balb c mice; keratinocyte; mast cell; ramalin

Indexed keywords

2,4 DINITROPHENOL; BETA N ACETYLHEXOSAMINIDASE; DERMATOLOGICAL AGENT; DEXAMETHASONE; HUMAN SERUM ALBUMIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOMODULATING AGENT; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PLANT EXTRACT; RAMALIN; RAMALINA TEREBRATA EXTRACT; RANTES; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; GLUTAMIC ACID DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOPIC DERMATITIS; BAGG ALBINO MOUSE; CELL LINE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DRUG EFFECT; DRUG ISOLATION; DRUG STRUCTURE; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME SYNTHESIS; HACAT CELL; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN E BLOOD LEVEL; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INTERLEUKIN 10 BLOOD LEVEL; INTERLEUKIN 4 BLOOD LEVEL; KERATINOCYTE; LICHEN (ORGANISM); MALE; MAST CELL; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS INHIBITION; RAMALINA TEREBRATA; RBL 2H3 CELL; SCRATCHING; SIGNAL TRANSDUCTION; SKIN DEFECT; TH2 CELL; TRANSCRIPTION INITIATION; ANIMAL; CHEMISTRY; DERMATITIS, ATOPIC; DRUG EFFECTS; SKIN; SKIN DISEASES;

ANIMALS; DERMATITIS, ATOPIC; GLUTAMATES; HUMANS; KERATINOCYTES; MALE; MAST CELLS; MICE; MICE, INBRED BALB C; SIGNAL TRANSDUCTION; SKIN; SKIN DISEASES;

EID: 84983437619     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5703     Document Type: Article

References (39)

1. Baldwin AS Jr. 2001. Series introduction: the transcription factor NFkappaBand human disease. J Clin Invest 107: 3–6.
2. Bell S, Degitz K, Quirling M, Jilg N, Page S, Brand K. 2003. Involvement of NF-kB signalling in skin physiology and disease. Cell Signal 15: 1–7.
3. Boguniewicz M, Leung DY. 2011. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 242: 233–246.
4. Bradding P, Roberts J, Britten K, et al. 1994. Interleukin-4,-5, and-6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 10: 471–480.
5. Elias PM, Schmuth M. 2009. Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr Opin Allergy Clin Immunol 9: 437–446.
6. Foo SY, Nolan GP. 1999. NF-kB to the rescue: RELs, apoptosis and cellular transformation. Trends Genet 15: 229–235.
7. Frossi B, Rivera J, Hirsch E, Pucillo C. 2007. Selective activation of Fyn/PI3K and p38 MAPK regulates IL-4 production in BMMC under nontoxic stress condition. J Immunol 178: 2549–2555.
8. Girolomoni G, Pastore S. 2001. The role of keratinocytes in the pathogenesis of atopic dermatitis. J Am Acad Dermatol 45: S25–S28.
9. Giustizieri ML, Mascia F, Frezzolini A, et al. 2001. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell–derived cytokines. J Allergy Clin Immunol 107: 871–877.
10. Han Y, Shikazono N. 2009. Measurement of liquid film thickness in micro square channel. Int J Multiph Flow 35: 896–903.
11. Homey B, Steinhoff M, Ruzicka T, Leung DY. 2006. Cytokines and chemokines orchestrate atopic skin inflammation. J Allergy Clin Immunol 118: 178–189.
12. Jang YJ, Koo HJ, Sohn EH, Kang SC, Rhee DK, Pyo S. 2015. Theobromine inhibits differentiation of 3 T3-L1 cells during the early stage of adipogenesis via AMPK and MAPK signaling pathways. Food Funct 6: 2365–2374.
13. Jin H, He R, Oyoshi M, Geha RS. 2009. Animal models of atopic dermatitis. J Invest Dermatol 129: 31–40.
14. Kawakami T, Ando T, Kimura M, Wilson BS, Kawakami Y. 2009. Mast cells in atopic dermatitis. Curr Opin Immunol 21: 666–678.
15. Konishi H, Tsutsui H, Murakami T, et al. 2002. IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/stat6 under specific pathogen-free conditions. Proc Natl Acad Sci U S A 99: 11340–11345.
16. Koranteng RD, Swindle EJ, Davis BJ, et al. 2004. Differential regulation of mast cell cytokines by both dexamethasone and the p38 mitogen-activated protein kinase (MAPK) inhibitor SB203580. Clin Exp Immunol 137: 81–87.
17. Krüger-Krasagakes S, Möller A, Kolde G, Lippert U, Weber M, Henz BM. 1996. Production of interleukin-6 by human mast cells and basophilic cells. J Invest Dermatol 106: 75–79.
18. Kwon DJ, Bae YS, Ju SM, Goh AR, Choi SY, Park J. 2011. Casuarinin suppresses TNF-α-induced ICAM-1 expression via blockade of NF-kB activation in HaCaT cells. Biochem Biophys Res Commun 409: 780–785.
19. Lazennec G, Richmond A. 2010. Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol Med 16: 133–144.
20. Lee E, Lee CG, Yim JH, Lee HK, Pyo S. 2015. Ramalin-Mediated Apoptosis Is Enhanced by Autophagy Inhibition in Human Breast Cancer Cells. Phytother Res 30: 426–438.
21. Leung DY, Bieber T. 2003. Atopic dermatitis. Lancet 361: 151–160.
22. Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA. 2004. New insights into atopic dermatitis. J Clin Invest 113: 651–657.
23. Müller K. 2001. Pharmaceutically relevant metabolites from lichens. Appl Microbiol Biotechnol 56: 9–16.
24. Matsuda H, Watanabe N, Geba GP, et al. 1997. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 9: 461–466.
25. Morrison DK. 2012. MAP kinase pathways. Cold Spring Harb Perspect Biol 4a011254: 1–5.
26. Park B, Yim JH, Lee HK, Kim BO, Pyo S. 2015. Ramalin inhibits VCAM-1 expression and adhesion of monocyte to vascular smooth muscle cells through MAPK and PADI4-dependent NF-kB and AP-1 pathways. Biosci Biotechnol Biochem 79: 539–552.
27. Paudel B, Bhattarai HD, Koh HY, et al. 2011. Ramalin, a novel nontoxic antioxidant compound from the Antarctic lichen Ramalina terebrata. Phytomedicine 18: 1285–1290.
28. Ranković B, Kosanić M. 2015. Lichens as a potential source of bioactive secondary metabolites. In Lichen Secondary Metabolites: Bioactive Properties and Pharmaceutical Potential, Ranković B (ed). Springer International Publishing: Switzerland; 1–26.
29. Romagnani S. 1991. Type 1 T helper and type 2 T helper cells: functions, regulation and role in protection and disease. Int J Clin Lab Res 21: 152–158.
30. Saeki H, Tamaki K. 2006. Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases. J Dermatol Sci 43: 75–84.
31. Schulze-Osthoff K, Ferrari D, Riehemann K, Wesselborg S. 1997. Regulation of NF-kappa B activation by MAP kinase cascades. Immunobiology 198: 35–49.
32. Sohn EH, Jang SA, Lee CH, et al. 2011. Effects of Korean red ginseng extract for the treatment of atopic dermatitis-like skin lesions in mice. J Ginseng Res 35: 479–486.
33. Tkaczyk C, Jensen BM, Iwaki S, Gilfillan AM. 2006. Adaptive and innate immune reactions regulating mast cell activation: from receptor-mediated signaling to responses. Immunol Allergy Clin North Am 26: 427–450.
34. Vestergaard C, Bang K, Gesser B, Yoneyama H, Matsushima K, Larsen CG. 2000. A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA + CCR4 + lymphocytes into lesional atopic dermatitis skin. J Invest Dermatol 115: 640–646.
35. Vestergaard C, Yoneyama H, Murai M, et al. 1999. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J Clin Invest 104: 1097–1105.
36. Werfel T. 2009. The role of leukocytes, keratinocytes, and allergen-specific IgE in the development of atopic dermatitis. J Invest Dermatol 129: 1878–1891.
37. Whitmarsh AJ. 2007. Regulation of gene transcription by mitogen-activated protein kinase signaling pathways. Biochim Biophys Acta 1773: 1285–1298.
38. Yoshimoto T, Mizutani H, Tsutsui H, et al. 2000. IL-18 induction of IgE: dependence on CD4+ T cells, IL-4 and STAT6. Nat Immunol 1: 132–137.
39. Yun JW, Kim H, Kang HJ, Koh JY, Kim BH. 2008. Comparative evaluation of animal models for atopic dermatitis in NC/Nga mice. Lab Anim Res 24: 59–66.